Site References

 (1) Lebwohl MG, et al. (2006). Vitiligo. Treatment of Skin Disease: Comprehensive Therapeutic Strategies (2nd edition, pp. 683-687). Elsevier.

(2) NIH. (2010 Nov). What Is Vitiligo? Fast Facts: An Easy-to-Read Series of Publications for the Public. National Institute of Arthritis and Musculoskeletal and Skin Disease. Retrieved September 2, 2013 from http://www.niams.nih.gov/Health_Info/Vitiligo/vitiligo_ff.asp.

(3) Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011 Sep;65(3):473-91.

(4) AAD. (2013). Vitiligo: Signs and symptoms. American Academy of Dermatology. Retrieved September 2, 2013 from http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/u---w/vitiligo/signs-symptoms

(5) AAD. (2013). Vitiligo: Who gets and causes. American Academy of Dermatology. Retrieved September 2, 2013 from http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/u---w/vitiligo/who-gets-causes

(6) Gawkrodger DJ. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. Br J Dermatol. 2009 Oct;161(4):721-2. 

(7) Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011 Sep;65(3):493-514.

(8) Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010 Jun;62(6):937-41. 

(9) Gawkrodger DJ, Ormerod AD, Shaw L et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-76.

(10) AAD. (2013). Vitiligo: Diagnosis, treatment, and outcome. American Academy of Dermatology. Retrieved September 2, 2013 from http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/u---w/vitiligo/diagnosis-treatment

(11) Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol. 2002 Aug;41(8):482-7.

(12) AVRF. (2013). Medical treatments. American Vitiligo Research Foundation. Retrieved September 2, 2013 from http://www.avrf.org/treatments/medical.htm

(13) Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum. 2011 Jun;40(6):512-531.

(14) Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol 2004;21: 495-8.

(15) AVRF. (2013). Surgical treatments. American Vitiligo Research Foundation. Retrieved September 2, 2013 from http://www.avrf.org/treatments/surgical.htm

(16) Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72(pt 3):385-96.

(17) Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol. 2002 Aug;41(8):482-7.

(18) Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995;190(3):223-9.

(19) Gawkrodger DJ. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. Br J Dermatol. 2009 Oct;161(4):721-2.

(20) Schallreuter KU, Krüger C, Würfel BA, Panske A, Wood JM. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol. 2008 Jul;47(7):743-53.

(21) Bakis-Petsoglou S, Le Guay JL, Wittal R. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. Br J Dermatol. 2009 Oct;161(4):910-7.

(22) Schallreuter KU. Effectiveness of pseudocatalase formulations in vitiligo. Clin Exp Dermatol. 2003 Sep;28(5):562-3.

(23) Schallreuter KU, Salem MA, Holtz S, Panske A. Basic evidence for epidermal H2O2/ONOO--mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS. FASEB J. 2013 Aug;27(8):3113-22.

(24) Bazian. (2013, May 12). No evidence of cure to prevent hair going grey. NIH Behind the headlines. Retrieved on September 2, 2013 from http://www.ncbi.nlm.nih.gov/pubmedhealth/behindtheheadlines/news/2013-05-12-no-evidence-of-cure-to-prevent-hair-going-grey/

(25) Genes. (2013, Sept 23). TYR. Genetics Homes Reference. Retrieved September 25, 2013 from http://ghr.nlm.nih.gov/gene/TYR

(26) Schallreuter KU, Moore J, Wood JM, Beazley WD, Peters EM, Marles LK, Behrens-Williams SC, Dummer R, Blau N, Thöny B. Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol. 2001 Jan;116(1):167-74.

(27) Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol 2007;21:1369-74. 

(28) Percivalle S, Piccinno R, Caccialanza M, Forti S. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Pediatr Dermatol. 2012 Mar-Apr;29(2):160-5.

(29) Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol. 2002 Nov;27(8):641-4.

(30) www.vitiligosupport.com/whatis.cfm Accessed April 18, 2005

(31) http://www.niams.nih.gov/hi/topics/vitiligo/vitiligo.htm Accessed April 18, 2005

(32) http://www.homephototherapy.com/vit-pcat.htm Accessed April 18, 2005

(33) http://www.brad.ac.uk/acad/biomed/STAFF/KUS/home.html Accessed April 19,2005

(34) Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudoctalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995;190(3):223-9.

(35) Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). International Journal of Dermatology. 2002;41(8):482-7.